Barclays’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $323K | Buy |
17,871
+1,986
| +13% | +$35.9K | ﹤0.01% | 3276 |
|
|
2025
Q1 | $325K | Sell |
15,885
-828
| -5% | -$16.9K | ﹤0.01% | 3081 |
|
|
2024
Q4 | $429K | Buy |
16,713
+9,117
| +120% | +$234K | ﹤0.01% | 3148 |
|
|
2024
Q3 | $126K | Buy |
7,596
+7,199
| +1,813% | +$119K | ﹤0.01% | 3683 |
|
|
2024
Q2 | $8K | Buy |
397
+303
| +322% | +$6.11K | ﹤0.01% | 4002 |
|
|
2024
Q1 | $2K | Sell |
94
-419
| -82% | -$8.92K | ﹤0.01% | 4103 |
|
|
2023
Q4 | $6K | Hold |
513
| – | – | ﹤0.01% | 4075 |
|
|
2023
Q3 | $5K | Buy |
+513
| New | +$5K | ﹤0.01% | 4111 |
|